Worth a Shot: New Preventive Options Available for Respiratory Syncytial Virus
Description

Highly contagious and often underestimated, respiratory syncytial virus (RSV) causes about 2.1 million outpatient visits in the United States every year. Fortunately, recent advancements in vaccines and antibody therapies can bolster prevention. Gain an overview of RSV, and learn about risk factors, prevention tools, and the important of raising awareness of RSV.

Summary
Availability: On-Demand
Access expires 14 days after start
Cost: Member: $20.00
Nonmember: $30.00
CEU Offered:
2.5 Gen/Clin CEUs
Recommended